All stock lists
Advent Convertible & Income Fund (New York Stock Exchange:AVK)
US · Delayed Price · Currency is USD
Financial Services · Asset Management - Income
$9.80-$0.26 (-2.53%)
Market cap
$433M
Insider Score
Health Score
Listed since
Apr 30, 2003
Website
Insider Score
68/ 100
AVK Insider Score
Bullish1 qualifying trade · 1 insider · $202.98K bought in the last 90 days
Financial Health Score
Fair
From AVK’s reported statements · Q2 2026 (trailing 12 months)
Profitability20 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $232.5M
- Net income
- $201.3M
- Net margin
- 86.6%
Leverage12 / 20
A manageable debt load.
- Total debt
- $350.0M
- Cash
- $6.5M
- Net debt / EBITDA
- 1.52x
Liquidity1 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $105.7M
- Current liabilities
- $192.0M
- Current ratio
- 0.55
Cash generation18 / 20
The business funds itself from operations.
- Operating cash flow
- $26.3M
- Free cash flow
- $26.3M
- FCF margin
- 11.3%
Dilution & runway4 / 20
Heavy dilution — shareholders are paying for the business.
- Shares outstanding
- 44.1M
- Share growth (1y)
- 20.6%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
AVK Income Statement
| Fiscal Period | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|---|---|
| Period Ending | Apr 30, 2026 | Oct 31, 2025 | Apr 30, 2025 | Oct 31, 2024 | Apr 30, 2024 | Oct 31, 2023 |
| Revenue | $49.87 M | $60.82 M | $82.49 M | $39.33 M | $18.66 M | $7.18 M |
| Revenue Growth (YoY) | 167.28 % | 747.16 % | 544.54 % | 246.51 % | -44.50 % | -81.68 % |
| Cost of Revenue | $3.78 M | $3.86 M | $7.70 M | $3.34 M | $3.31 M | $3.39 M |
| Gross Profit | $46.09 M | $56.95 M | $37.40 M | $39.33 M | $15.34 M | $3.79 M |
| SG&A Expense | $0.00 | $0.00 | $0.00 | -$8.63 M | -$59.77 M | $0.00 |
| R&D Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $3.42 M | -$61.43 M | $20.80 M | -$8.63 M | -$59.77 M | $23.78 M |
| Operating Income | $42.67 M | $118.38 M | $33.20 M | $47.95 M | $75.12 M | -$19.99 M |
| Pretax Income | $34.52 M | $110.59 M | $16.10 M | $40.05 M | $66.45 M | -$28.94 M |
| Tax Provision | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $34.52 M | $110.59 M | $16.10 M | $40.05 M | $66.45 M | -$28.94 M |
| EPS (Basic) | $0.78 | $2.51 | $0.36 | $1.36 | $2.78 | -$0.84 |
| EPS (Diluted) | $0.78 | $2.51 | $0.36 | $1.36 | $2.78 | -$0.84 |
| Shares Outstanding | 44.15 M | 44.15 M | 44.15 M | 44.15 M | 36.60 M | 34.59 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
